
Tesamorelin · 10 mg
Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.
Metabolic Research
Incretin and growth-factor research peptides for metabolic studies, stocked in Canada and shipped in 1–3 business days with lot-matched documentation.

Growth hormone-releasing factor analogue studied in metabolic and body-composition research models.

Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.



Triple-agonist research peptide (GIP / GLP-1 / glucagon) in a 10 mg batch-coded vial.

Triple-agonist research peptide (GIP / GLP-1 / glucagon) in a 20 mg batch-coded vial.
Our metabolic range covers the incretin receptor pathways most cited in current metabolic literature — GLP-1 receptor agonists, dual GIP/GLP-1 agonists and triple GIP/GLP-1/glucagon agonists — alongside growth hormone-releasing factor analogues such as Tesamorelin.
Every vial is lyophilised, sealed and batch-coded, and each lot is third-party tested by HPLC and mass spectrometry. The certificate of analysis for the lot printed on your label is available on request.
All material is held in temperature-controlled inventory in Canada, so orders clear no border and no customs queue.
For laboratory research use only. Not for human or veterinary use. See our terms of sale.